Volume: 54 Issue: 2
Year: 2023, Page: 374-381, Doi: https://doi.org/10.51966/jvas.2023.54.2.374-381
Received: Nov. 5, 2022 Accepted: Jan. 5, 2023 Published: June 30, 2023
The present study was carried out with the objective of evaluating the response to a combination therapy of enalapril and torasemide in dogs with mitral valve disease (MVD). Dogs diagnosed with stage C of MVD as per the American College of Veterinary Internal Medicine guidelines were included in the study. Treatment was initiated with enalapril at 0.5 mg/kg BID and torasemide at 0.2 mg/kg OD orally on 0th day. Detailed clinical examination with special reference to the cardiovascular system including measurement of blood pressure, radiographic, electrocardiographic and echocardiographic parameters of the animals were performed on 0th and 30th day of treatment. The treatment was well tolerated by all the animals. Amelioration of clinical signs with a noticeable reduction in cough was noticed in all the animals. On 30th day of treatment, a significant decrease was noticed in the vertebral heart score and left ventricular internal diameter during diastole and a non-significant decrease was noticed in left atrium to aortic root ratio, left ventricular internal diameter during systole, with a considerable reduction in severity of mitral regurgitation. Post- treatment clearing of lung fields was noticed in dogs with radiographic evidence of pulmonary oedema on 0th day. In addition to this, ventricular premature complexes noticed in three animals pre- treatment was not noticed post treatment.
Keywords: Mitral valve disease, Enalapril, Torasemide
Abbott, J.A. 2008. Acquired valvular disease. In: Tilley, L.P., Smith Jr., F.W.K., Oyama, M.A. and Sleeper, M. (eds.). Manual of Canine and Feline Cardiology. (4th Ed.) Saunders Elsevier, Missouri, pp.110-138.
Aiswariya, R., Ajithkumar, S., Pillai, U.N., Unny, N.M., Jayavardhanan, K.K. and Sunanda, C. 2019. Evaluation of cardiac function in hypothyroid dogs using electrocardiography and echocardiography. J. Vet. Anim. Sci. 50: 49-53.
Atkins, C.E. and Haggstrom, J. 2012. Pharmacologic management of myxomatous mitral valve disease in dogs. J. Vet. Cardiol. 14: 165-184.
Bakirel, U., Gunes, S., Meral, Y. and Bakirel, T. 2008. Subacute echocardiographic effects of ACE inhibitors in the dogs with severe mitral regurgitation. Bull. Vet. Inst. Pulawy. 52: 471-475.
Beaumier, A., Rush, J.E., Yang, V.K. and Freeman, L.M. 2018. Clinical findings and survival time in dogs with advanced heart failure. J. Vet. Intern. Med. 32: 944-950.
Bonagura, J.D. and Schober, K.E. 2009. Can ventricular function be assessed by echocardiography in chronic canine mitral valve disease? J. Small Anim. Pract. 50: 12-24.
Boon, J.A. 2011. Veterinary Echocardiography. (2nd Ed.). Wiley-Blackwell, Ames, Iowa, USA, 632p.
Borgarelli, M., Ferasin, L., Lamb, K., Chiavegato, D., Bussadori, C., D'Agnolo, G., Migliorini, F., Poggi, M., Santilli, R.A., Guillot, E. and Garelli-Paar, C. 2021. The predictive value of clinical, radiographic, echocardiographic variables and cardiac biomarkers for assessing risk of the onset of heart failure or cardiac death in dogs with preclinical myxomatous mitral valve disease enrolled in the DELAY study. J. Vet. Cardiol. 36: 77-88.
Borgarelli, M., Tarducci, A., Zanatta, R. and Haggstrom, J. 2007. Decreased systolic function and inadequate hypertrophy in large and small breed dogs with chronic mitral valve insufficiency. J. Vet. Intern. Med. 21: 61-67.
Bruler, B.C., Jojima, F.S., Dittrich, G., Giannico, A.T. and Sousa, M.G. 2018. QT instability, an indicator of augmented arrhythmogenesis, increases with the progression of myxomatous mitral valve disease in dogs. J. Vet. Cardiol. 20: 254-266.
Buchanan, J.W. and Bucheler, J. 1995. Vertebral scale system to measure canine heart size in radiographs. J. Am. Vet. Med. Ass. 206: 194-194.
Crosara, S., Borgarelli, M., Perego, M., Haggstrom, J., La Rosa, G., Tarducci, A. and Santilli, R.A. 2010. Holter monitoring in 36 dogs with myxomatous mitral valve disease. Aust. Vet. J. 88: 386-392.
Dillon, A.R., Dell’Italia, L.J., Tillson, M., Killingsworth, C., Denney, T., Hathcock, J. and Botzman, L. 2012. Left ventricular remodelling in preclinical experimental mitral regurgitation of dogs. J. Vet. Cardiol. 14: 73-92.
Guglielmini, C. 2003. Cardiovascular diseases in the ageing dog: diagnostic and therapeutic problems. Vet. Res. Commun. 27: 555-560.
Haggstrom, J., Hoglund, K. and Borgarelli, M. 2009. An update on treatment and prognostic indicators in canine myxomatous mitral valve disease. J. Small Anim. Pract. 50: 25-33.
Kim, H.T., Han, S.M., Song, W.J., Kim, B., Choi, M., Yoon, J. and Youn, H.Y. 2017. Retrospective study of degenerative mitral valve disease in small-breed dogs: survival and prognostic variables. J. Vet. Sci. 18: 369-376.
Lefebvre, H.P., Brown, S.A., Chetboul, V., King, J.N., Pouchelon, J.L. and Toutain, P.L. 2007. Angiotensin-converting enzyme inhibitors in veterinary medicine. Curr. Pharm. Des. 13: 1347-1361.
Petric, A.D. 2015. Myxomatous mitral valve disease in dogs- An update and perspectives. Maced. Vet. Rev. 38: 13-20.
Petrus, L.C., Castro, J.R., Mantovani, M.M., Gimenes, A.M., Duarte, C.N., Goldfeder, G.T., Schwartz, D.S. and Larsson, M.H. 2018. Left atrial size and contractile function in healthy dogs and dogs with chronic mitral valve disease. Braz. J. Vet. Res. Anim. Sci. 38: 1622-1630.
Revathi, K., Unny, N.M., Pillai, U.N., Uma, R. and Ajithkumar, S. 2020. Effect of coenzyme q10 supplementation on total antioxidant status and lipid peroxides levels in dogs with chronic valvular heart disease. J. Vet. Anim. Sci. 51: 175-178.
Rosa, L.J., Lanzi, T.D., Romao, L.M.M. and Romao, F.G. 2019. Prevalence study of arrhythmia in dogs affected for mitral valve disease. Acta Vet. Bras. 13: 140-146.
Unny, M.N. 2014. Diagnosis and management of mitral valve insufficiency in dogs. Ph.D. thesis, Kerala Veterinary and Animal Sciences University, Pookode, 140p.
Werner, C., Poss, J. and Bohm, M. 2010. Optimal Antagonism of the Renin-Angiotensin-Aldosterone System. Drugs. 70: 1215-1230.
© 2023 Greeshma et al. This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Greeshma, J., Rajan, S.K., Pillai, U.N., Unny, N.M. andGleeja, V.L. 2023.Evaluation of response to combination therapy with enalapril and torasemide in dogs with mitral valve disease.
J. Vet. Anim. Sci. 54(2):374-381 DOI: https://doi.org/10.51966/jvas.2023.54.2.374-381